{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T10:44:28Z","timestamp":1749725068988,"version":"3.37.3"},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T00:00:00Z","timestamp":1658016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T00:00:00Z","timestamp":1658016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Urothelial carcinoma of the bladder accounts for nearly 90% of all bladder cancers. Risk factors include cigarette smoke, chronic cystitis, and human papilloma virus infection. It is commonly diagnosed by hematuria, obstructive voiding, and irritative symptoms.\u00a0Despite the prevalence of urothelial carcinoma, elevation of \u03b2-human chorionic gonadotropin in the setting of these malignancies is not common. This case report informs gynecologic practitioners to consider urologic causes of \u03b2-human chorionic gonadotropin elevation even in the setting of recent spontaneous abortion and details comprehensive review of diagnostic testing in the setting of \u03b2-human chorionic gonadotropin elevation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 49-year-old, non-Hispanic Caucasian woman, former smoker, with a history of polycystic ovary syndrome, high-risk human chorionic gonadotropin infection, and hypertension, underwent vacuum-assisted aspiration for significant vaginal bleeding in the setting of incomplete abortion. Fetal tissue was confirmed pathologically. Human chorionic gonadotropin levels decreased to 12.5\u00a0mU\/mL and were no longer followed due to resumption of menses. Five months later during routine preoperative evaluation for orthopedic surgery, her human chorionic gonadotropin level was found to be elevated. She was also noted to have persistent asymptomatic hematuria. She completed an extensive gynecologic and urologic work-up, including hysteroscopy, dilation and curettage, methotrexate therapy, computerized tomographic imaging, and cystoscopy to finally arrive at the diagnosis of urothelial carcinoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Only a rare subset of urothelial carcinomas secretes \u03b2-human chorionic gonadotropin. Therefore, diagnosis of urothelial carcinoma is typically achieved by urine cytology with cystoscopic biopsy. Although rare, urothelial carcinoma should be considered in patients with risk factors presenting with persistently elevated beta-human chorionic gonadotropin.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03511-7","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T23:02:33Z","timestamp":1658012553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Persistently elevated \u03b2-human chorionic gonadotropin level after vacuum-assisted uterine aspiration: a case report"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2702-7823","authenticated-orcid":false,"given":"Annika","family":"Sinha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betsy","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,17]]},"reference":[{"issue":"4","key":"3511_CR1","first-page":"289","volume":"54","author":"K Sugimoto","year":"2008","unstructured":"Sugimoto K, Hashimoto K, Esa A, Park YC. Beta-hCG producing urothelial carcinoma of the urinary bladder: a case report. Hinyokika Kiyo. 2008;54(4):289\u201392.","journal-title":"Hinyokika Kiyo"},{"key":"3511_CR2","first-page":"20","volume":"7","author":"AK Venyo","year":"2010","unstructured":"Venyo AK, Herring D, Greenwood H, Maloney DJ. The expression of beta human chorionic gonadotrophin (\u03b2-HCG) in human urothelial carcinoma. Pan Afr Med J. 2010;7:20.","journal-title":"Pan Afr Med J"},{"issue":"3","key":"3511_CR3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.5980\/jpnjurol1989.87.643.inJapanese","volume":"87","author":"K Morisue","year":"1996","unstructured":"Morisue K, Yamanaka N, Eto H, Kamidono S, Nishimura R. Ectopic production of HCG beta by bladder carcinoma in vitro and in vivo. Nihon Hinyokika Gakkai Zasshi. 1996;87(3):643\u20139. https:\/\/doi.org\/10.5980\/jpnjurol1989.87.643.inJapanese.","journal-title":"Nihon Hinyokika Gakkai Zasshi."},{"issue":"1","key":"3511_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00345-018-2503-4","volume":"37","author":"F Soria","year":"2019","unstructured":"Soria F, Krabbe LM, Todenh\u00f6fer T, et\u00a0al. Molecular markers in bladder cancer. World J Urol. 2019;37(1):31\u201340. https:\/\/doi.org\/10.1007\/s00345-018-2503-4.","journal-title":"World J Urol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03511-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03511-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03511-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T23:02:51Z","timestamp":1658012571000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03511-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,17]]},"references-count":4,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3511"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03511-7","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2022,7,17]]},"assertion":[{"value":"19 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board approval was not required for this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}